Sun, Zhi-Jun <br/><br/>
Curcumin dually inhibits both mammalian target of rapamycin and nuclear factor-κB pathways through a crossed phosphatidylinositol 3-kinase/Akt/IκB kinase complex signaling axis in adenoid cystic carcinoma.  [electronic resource] 

 -  Molecular pharmacology  Jan 2011 
 - 106-18 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1521-0111 
<br/><br/><label>Standard No.: </label>10.1124/mol.110.066910  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Carcinoma, Adenoid Cystic--drug therapy<br/>Cell Line<br/>Cell Line, Tumor<br/>Chickens<br/>Curcumin--pharmacology<br/>Female<br/>I-kappa B Proteins--antagonists & inhibitors<br/>Mice<br/>Mice, Inbred BALB C<br/>Mice, Nude<br/>NF-kappa B--antagonists & inhibitors<br/>Phosphatidylinositol 3-Kinase--metabolism<br/>Phosphoinositide-3 Kinase Inhibitors<br/>Proto-Oncogene Proteins c-akt--metabolism<br/>Random Allocation<br/>Rats<br/>Signal Transduction--drug effects<br/>TOR Serine-Threonine Kinases--antagonists & inhibitors<br/>Xenograft Model Antitumor Assays--methods